Development of Pediatric ARV Drugs – FDA Perspective Linda L. Lewis, M.D. Medical Officer Division of Antiviral Drug Products U.S. Food and Drug Administration.
Immune Activation/Inflammation and HIV Disease Prof. Georg Behrens Department for Clinical Immunology and Rheumatology Hannover Medical School Germany.
FQHCs and FQHC Look-alikes: A Sustainable Business Model for RW Part C Programs.
The Ryan White HIV/AIDS Treatment Modernization Act of 2006 August 2008 Council of Community Services Virginia HIV/AIDS Resources & Consultation Center.
2010-2011 Ryan White Services Report Data CAPT Tracy Matthews Acting Director, Division of Policy and Data E. Amaka Nwankwo-Igomu Chief, Data Management.
